sxtchina.com (SXTC): Rasio utang marang kapitalisasi buku

Logo korporat perusahaan China SXT Pharmaceuticals, Inc. (SXTC)

This chart illustrates the market value of China SXT Pharmaceuticals (SXTC), which currently stands at 0.04, supported by the modernization of China's traditional medicine production plants and growth in sales through government agencies. China SXT Pharmaceuticals (SXTC) maintains its position in a mature domestic market by raising quality standards, while simultaneously implementing environmental filters and strictly tracking the origin of natural raw materials.

SXTC China SXT Pharmaceuticals, Inc.: Utang marang nilai buku ing interval 04.07.2022 - 29.10.2026
Produk sing diprodhuksi China SXT Pharmaceuticals, Inc.

To assess the issuer's financial stability, the ratio of total liabilities to equity on the balance sheet is used, which determines the extent to which the financing structure depends on borrowed funds. By analyzing the debt-to-book capitalization metric for China SXT Pharmaceuticals (SXTC) on the GURU.Markets platform, an investor can see how effectively China SXT Pharmaceuticals balances its credit load to expand within the Asian generics sector without the risk of default.

Perusahaan pesaing

Utang-utang marang kapitalisasi buku HLN (Haleon plc)|Utang-utang marang kapitalisasi buku kenvue.com KVUE|VRNA - Rasio utang marang kapitalisasi buku|Rasio utang marang aset resik MENS (Jyong Biotech Limited)|Ligand Pharma (LGND) - Rasio utang marang kapitalisasi buku|Utang marang nilai buku Amneal Corp|PRGO (Perrigo Company plc) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku alvotech.com|Utang marang nilai buku LQDA (Liquidia)|GLPG (Galapagos N.V.) - Rasio utang marang aset resik|Rasio utang marang kapitalisasi buku ANI Pharma ANIP|Afrezza (MNKD) - Utang-utang marang nilai buku|AMPH: Utang marang nilai buku|pacira.com - Utang marang modal buku|SPRY: Utang-utang marang kapitalisasi buku|Theravance Biopharma Inc - Rasio utang marang aset resik|AQST (Aquestive Pharma) - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku scPharma SCPH|Rasio utang marang kapitalisasi buku Tectonic Therapeutic, Inc. (TECX)|TNXP (tonixpharma.com) - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku EPRX (Eupraxia Pharmaceuticals Inc.)|BHST - Utang marang nilai buku|Invizyne Technologies, Inc. - Utang-utang marang kapitalisasi buku|Rasio utang marang aset resik ORMP (Oramed Pharmaceuticals)|ENTX: Utang-utang marang kapitalisasi buku|HYFT - Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku ABVC BioPharma, Inc.|Rasio utang marang nilai buku CPIX (Cumberland Pharmaceuticals Inc)|Utang-utang marang kapitalisasi buku QNTM|Utang-utang marang kapitalisasi buku FibroGen Corporation (FGEN)|Telomir Pharmaceuticals - Utang marang nilai buku|Rasio utang marang aset resik RANI|SNYR - Rasio utang marang kapitalisasi buku|Utang-utang marang aset resik Rallybio Corporation RLYB|LEXX (lexariabioscience.com) - Utang marang nilai buku|Rasio utang marang nilai buku PULM|Utang marang nilai buku PTHL|APM (Aptorum) - Utang marang modal buku|Utang marang nilai buku LYRA (Lyra Therapeutics)|IBO (Impact BioMedical, Inc.) - Rasio utang marang aset resik|Rasio utang marang kapitalisasi buku TNF Pharmaceuticals, Inc. TNFA|YCBD (cbdMD Inc.) - Rasio utang-utang marang kapitalisasi buku|PainReform Ltd. - Utang-utang marang kapitalisasi buku|Rasio utang marang aset resik CYTO (Altamira Therapeutics)|LIPO: Utang-utang marang kapitalisasi buku|OptiNose Inc (OPTN) - Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku Pieris|PROC: Rasio utang marang aset resik|Rasio utang marang kapitalisasi buku Petros Pharmaceuticals (PTPI)|Utang marang nilai buku qlsyy.net QLI|Utang-utang marang kapitalisasi buku SLRN (ACELYRIN)|Utang-utang marang kapitalisasi buku TFF Pharmaceuticals Inc. TFFP